Showing results (11-20 of 50) with videos related to
Sort By:
Pageof 5
Journal of Psychiatric Research|March 9, 2004
Development of a computerized assessment of clinician adherence to a treatment guideline for patients with bipolar disorderEllen B Dennehy, Trisha Suppes, A John Rush, et al.Neurology. Clinical Practice|March 9, 2023
Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study FindingsAlette M Wessels, Ellen B Dennehy, Sherie A Dowsett, et al.Current Medical Research and Opinion|August 23, 2024
Understanding the impact of slowing disease progression for individuals with biomarker-confirmed early symptomatic Alzheimer's diseaseUrvi Desai, Dumingu Aparna Gomes, Julie Chandler, et al.Psychiatry Research|July 21, 2004
Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorderEllen B Dennehy, Trisha Suppes, M Lynn Crismon, et al.The Patient|March 7, 2026
Patients' Experiences of Obstructive Sleep Apnea and Tirzepatide Treatment: An Exit Interview StudyShraddha Shinde, Chisom Kanu, Oralee J Varnado, et al.Journal of Affective Disorders|May 24, 2011
Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)Ellen B Dennehy, Lauren B Marangell, Michael H Allen, et al.Pain and Therapy|April 25, 2020
Acute Migraine Prescription Patterns Vary by Baseline Cardiovascular Risk and Clinical Characteristics: A Real-World Evidence StudyHu Li, Maurice Vincent, Xiang Zhang, et al.Sleep Medicine|August 7, 2025
Effect of tirzepatide treatment on patient-reported outcomes among SURMOUNT-OSA participants with obstructive sleep apnea and obesityChisom Kanu, Shraddha Shinde, Sujatro Chakladar, et al.Current Medical Research and Opinion|March 31, 2021
Lasmiditan efficacy in migraine attacks with mild vs. moderate or severe painMario F P Peres, Raghavendra Vasudeva, Simin K Baygani, et al.Brain : a Journal of Neurology|May 28, 2019
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migrainePeter J Goadsby, Linda A Wietecha, Ellen B Dennehy, et al.Pageof 5